跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Jitai
首页
药物
Jitai
Jitai
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
RAPIDLY METABOLIZED LIPID COMPOUND
US 20250026713 A1
申请人: BEIJING JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2023
CN
EP
US
WO
9 件公开
WO 2026061537 A1
申请人: BEIJING JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2024
WO
US 20250161482 A1
申请人: BEIJING JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2024
US
LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF
EP 4694871 A1
申请人: BEIJING JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2023
CN
EP
WO
6 件公开
US 20250090472 A1
申请人: BEIJING JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2023
CN
US
2 件公开
Ionizable lipid compounds
US 12162819 B2
申请人: BEIJING JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2022
CN
EP
US
WO
5 件公开
US 2024245782 A1
申请人: BEIJING JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2024
US
2 件公开
LIPID NANOPARTICLES
US 2023346702 A1
申请人: BEIJING JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2022
CN
EP
US
WO
5 件公开
LIPID-BASED TOPICAL INJECTION FORMULATIONS
EP 4385523 A1
申请人: BEIJING JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2022
EP
US
3 件公开
Neratinib-cyclodextrin composition and method for preparing same
US 12263226 B1
申请人: HANGZHOU JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2024
US
WO
2 件公开
LIPID NANOPARTICLE TARGETING MUSCLE
WO 2025180480 A1
申请人: BEIJING JITAI PHARMACEUTICAL TECH CO LTD
优先权: 2024
WO
2 件公开
IONIZABLE LIPID CONTAINING HETEROAROMATIC RING STRUCTURE
WO 2026081995 A1
申请人: BEIJING JITAI LIFE SCIENCES LTD
优先权: 2024
WO
2 件公开
Blood-supplementing blood-nourishing pure Chinese medicine preparation, preparation process and application
CN 1428169 A
申请人: JITAI AN SICHUAN PHARMACEUTICA
优先权: 2002
CN
Arthrosis pill
CN 101380425 B
申请人: JITAI QUAN
优先权: 2008
CN
第 1 / 9 页
上一页
下一页
药物
反馈